Effect of repeated treatment with high doses of selegiline on behaviour, striatal dopaminergic transmission and tyrosine hydroxylase mRNA levels

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 365, Issue 1, 2002, Pages 22-28

  Themann, C ^a   Alvarez Fischer, D ^a   Gross S ^a   Westermann, R ^a   Weihe, E ^a   Kuschinsky, K ^a   Schafer M ^a   Ferger, B ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b ETH ZURICH   (Switzerland)

Author keywords

Dopamine; Selegiline; Sensitization; Tyrosine hydroxylase

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; MESSENGER RNA; SELEGILINE; SODIUM CHLORIDE; SULFUR 35; TYROSINE 3 MONOOXYGENASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; DOPAMINERGIC TRANSMISSION; DOWN REGULATION; DRUG EFFECT; IN SITU HYBRIDIZATION; LOCOMOTION; MALE; MESENCEPHALON; MICRODIALYSIS; NONHUMAN; RAT; SENSITIZATION; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ANIMALS; ANTIPARKINSON AGENTS; CORPUS STRIATUM; DOPAMINE; DRUG ADMINISTRATION SCHEDULE; IN SITU HYBRIDIZATION; INJECTIONS, INTRAPERITONEAL; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; RNA, MESSENGER; SELEGILINE; TYROSINE 3-MONOOXYGENASE;

EID: 0036139914     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-001-0492-z     Document Type: Article

References (29)

1. Tyrosine hydroxylase: Mechanisms of oxygen radical formation
2. The associative type of sensitization to d-amphetamine is expressed as an NO-dependent dramatic increase in extracellular dopamine in the nucleus accumbens
3. Sensitization to the behavioural effects of cocaine: Alteration in tyrosine hydroxylase or endogenous opioid mRNAs are not necessarily involved
4. Atypical prodynorphin gene expression in corticosteroid-producing cells of the rat adrenal gland
5. Effects of α-phenyl-tert-butylnitrone and selegiline on hydroxyl free radicals in rat striatum produced by local application of glutamate
6. Quantitative film autoradiography for tritium: Methodological considerations
7. Complete coding sequence of rat tyrosine hydroxylase mRNA
8. Pharmakokinetic aspects of l-deprenyl (selegiline) and its metabolites
9. R-(-)-deprenyl (selegiline, movergan) facilitates the activity of the nigrostriatal dopaminergic neuron
10. Rationale for (-)deprenyl (selegiline) medication in Parkinson's disease and in prevention of age-related nigral changes
11. L-deprenyl reduces brain damage in rats exposed to transient hypoxia-ischemia
12. Behavioral sensitization and extracellular dopamine responses to amphetamine after various treatments
13. Reduced striatal tyrosine hydroxylase activity is not accompanied by change in responsiveness of dopaminergic receptors following chronic treatment with deprenyl
14. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo
15. Sensitization phenomena after repeated administration of cocaine or d-amphetamine in rats: Associative and non-associative mechanisms and the role of dopamine in the striatum
16. l-Methamphetamine pharmacokinetics and pharmacodynamics for assessment of in vivo deprenyl-derived l-methamphetamine
17. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promotor
18. Neural substrates mediating context-dependent sensitization to psychostimulants
19. Deprenyl in the treatment of Parkinson's disease: Clinical effects and speculations on mechanism of action
20. Drug-environment interaction: Context dependency of cocaine-induced behavioral sensitization
21. Deprenyl induces the tyrosine hydroxylase enzyme in the rat dopaminergic nigrostriatal system
22. Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage
23. Sensitization to d-amphetamine after its repeated administration: Evidence in EEG and behaviour
24. The role of the nucleus accumbens in sensitization to drugs of abuse
25. Tolerance and sensitization to the behavioural effects of drugs
26. Chronic selegiline administration transiently decreases tyrosine hydroxylase activity and mRNA in the rat nigrostriatal pathway
27. The amphetamine-like reinforcing effect and mechanism of L-deprenyl on conditioned place preference in mice
28. Are metabolites of l-deprenyl (selegiline) useful or harmful? Indications from pre-clinical research